0000899243-22-034463.txt : 20221028 0000899243-22-034463.hdr.sgml : 20221028 20221028183619 ACCESSION NUMBER: 0000899243-22-034463 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221027 FILED AS OF DATE: 20221028 DATE AS OF CHANGE: 20221028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reed Joshua CENTRAL INDEX KEY: 0001746541 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40657 FILM NUMBER: 221343346 MAIL ADDRESS: STREET 1: C/O ALDEYRA THERAPEUTICS, INC. STREET 2: 131 HARTWELL AVENUE, SUITE 320 CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Therapeutics, Inc. CENTRAL INDEX KEY: 0001850838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: (617) 949-4360 MAIL ADDRESS: STREET 1: 20 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-27 0 0001850838 Omega Therapeutics, Inc. OMGA 0001746541 Reed Joshua C/O OMEGA THERAPEUTICS, INC. 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 0 1 0 0 Chief Financial Officer Option (Right to Buy) 5.27 2022-10-27 4 A 0 55000 0.00 A 2032-10-26 Common Stock 55000 55000 D The options vest and become exercisable as to 25% of the underlying shares on October 27, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on October 27, 2026. /s/ Barbara Chan as Attorney-in-Fact for Joshua Reed 2022-10-28